Capital Advisory Group Advisory Services’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,823
| Closed | -$584K | – | 87 |
|
|
2025
Q4 | $584K | Sell |
2,823
-700
| -20% | -$138K | 0.17% | 103 |
|
|
2025
Q3 | $653K | Sell |
3,523
-2,180
| -38% | -$373K | 0.2% | 98 |
|
|
2025
Q2 | $871K | Buy |
5,703
+129
| +2% | +$19.8K | 0.31% | 75 |
|
|
2025
Q1 | $925K | Buy |
5,574
+148
| +3% | +$23.2K | 0.35% | 73 |
|
|
2024
Q4 | $785K | Buy |
5,426
+1,239
| +30% | +$192K | 0.28% | 84 |
|
|
2024
Q3 | $679K | Buy |
4,187
+1
| +0% | +$159 | 0.27% | 80 |
|
|
2024
Q2 | $612K | Sell |
4,186
-3,868
| -48% | -$575K | 0.26% | 86 |
|
|
2024
Q1 | $1.27M | Buy |
8,054
+226
| +3% | +$36K | 0.6% | 51 |
|
|
2023
Q4 | $1.23M | Sell |
7,828
-263
| -3% | -$40.3K | 0.66% | 46 |
|
|
2023
Q3 | $1.26M | Buy |
+8,091
| New | +$1.34M | 0.72% | 41 |
|
|
2023
Q2 | – | Sell |
-8,418
| Closed | -$1.3M | – | 112 |
|
|
2023
Q1 | $1.3M | Buy |
8,418
+160
| +2% | +$25.8K | 0.78% | 36 |
|
|
2022
Q4 | $1.46M | Sell |
8,258
-61
| -0.7% | -$10.5K | 0.99% | 29 |
|
|
2022
Q3 | $1.36M | Sell |
8,319
-391
| -4% | -$66.2K | 0.94% | 33 |
|
|
2022
Q2 | $1.54M | Sell |
8,710
-101
| -1% | -$18K | 0.92% | 35 |
|
|
2022
Q1 | $1.56M | Buy |
8,811
+318
| +4% | +$54.1K | 0.72% | 40 |
|
|
2021
Q4 | $1.45M | Sell |
8,493
-3,685
| -30% | -$603K | 0.63% | 45 |
|
|
2021
Q3 | $1.97M | Buy |
12,178
+637
| +6% | +$109K | 0.71% | 38 |
|
|
2021
Q2 | $1.9M | Sell |
11,541
-1,423
| -11% | -$236K | 0.69% | 38 |
|
|
2021
Q1 | $2.13M | Buy |
12,964
+896
| +7% | +$145K | 0.83% | 34 |
|
|
2020
Q4 | $1.9M | Buy |
12,068
+2,214
| +22% | +$327K | 0.8% | 31 |
|
|
2020
Q3 | $1.47M | Buy |
9,854
+337
| +4% | +$49.9K | 0.76% | 32 |
|
|
2020
Q2 | $1.34M | Buy |
9,517
+3,239
| +52% | +$472K | 0.75% | 33 |
|
|
2020
Q1 | $830K | Buy |
6,278
+1,159
| +23% | +$164K | 1.03% | 30 |
|
|
2019
Q4 | $741K | Buy |
5,119
+2,882
| +129% | +$391K | 0.39% | 46 |
|
|
2019
Q3 | $290K | Sell |
2,237
-13
| -0.6% | -$1.71K | 0.19% | 60 |
|
|
2019
Q2 | $313K | Sell |
2,250
-39
| -2% | -$5.4K | 0.21% | 57 |
|
|
2019
Q1 | $321K | Buy |
2,289
+90
| +4% | +$12.1K | 0.23% | 54 |
|
|
2018
Q4 | $285K | Sell |
2,199
-5,039
| -70% | -$703K | 0.22% | 54 |
|
|
2018
Q3 | $993K | Buy |
7,238
+310
| +4% | +$41.2K | 0.66% | 27 |
|
|
2018
Q2 | $841K | Buy |
6,928
+54
| +0.8% | +$6.74K | 0.61% | 27 |
|
|
2018
Q1 | $877K | Buy |
+6,874
| New | +$929K | 0.64% | 28 |
|
Other funds holding JNJ
VCM
VPM
Capital Advisory Group Advisory Services's JNJ Position: Q1 2026 in Review
Capital Advisory Group Advisory Services sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 2,823 shares — an estimated $584K sold.
Capital Advisory Group Advisory Services first reported a position in JNJ in Q1 2018 and held it in 31 quarters. The position peaked at $2.13M in Q1 2021. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Capital Advisory Group Advisory Services reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- Capital Advisory Group Advisory Services sold 2,823 Johnson & Johnson shares in Q1 2026, an estimated $584K.
- Capital Advisory Group Advisory Services first reported a position in Johnson & Johnson in Q1 2018 and held it in 31 quarters.
- Capital Advisory Group Advisory Services's Johnson & Johnson position peaked at $2.13M in Q1 2021.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Capital Advisory Group Advisory Services's 13F filing for Q1 2026, filed 15 Apr 2026.